Randomised trials of TAVI in intermediate-risk patients - Implications for everyday practice

Chairpersons: N. Moat, S. Windecker
React@PCR Moderator: T. Patterson

Learning Objectives

  • To learn more about the outcome of TAVI and surgical aortic valve replacement in intermediate surgical risk patients
  • To understand how your Heart Team should apply this information in routine clinical practice
  • To appreciate the remaining unanswered questions and how these will be addressed in future trials

Presentations available when logged in:

  • Session objectives
  • The take-home messages from PARTNER 2
  • The new information from SURTAVI
  • How do these trials affect my daily practice?
  • How do these trials fit with new European and US guidelines?
  • Unanswered questions and forthcoming trials